(Q37506346)

20 August 2017

1 reference

title

The use of surrogate vascular markers in youth at risk for premature cardiovascular disease (English)

1 reference

20 August 2017

main subject

cardiovascular disease

1 reference

1 reference

McNeal CJ

1

1 reference

20 August 2017

Wilson DP

2

1 reference

20 August 2017

Christou D

3

1 reference

20 August 2017

Bush RL

4

1 reference

20 August 2017

Shepherd LG

5

1 reference

20 August 2017

Santiago J

6

1 reference

20 August 2017

Wu GY

7

1 reference

20 August 2017

publication date

1 March 2009

1 reference

Journal of Pediatric Endocrinology and Metabolism

20 August 2017

published in

1 reference

20 August 2017

volume

22

1 reference

20 August 2017

issue

3

1 reference

20 August 2017

page(s)

195-211

1 reference

Surrogate endpoints: a basis for a rational approach

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Introduction: utilization of surrogate markers of atherosclerosis for the clinical development of pharmaceutical agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Prevention of cardiovascular risk factors in the first place

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Interrelationship between non-invasive measurements of atherosclerosis: flow-mediated dilation of brachial artery, carotid intima-media thickness and pulse wave velocity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Clinical review 168: What vascular ultrasound testing has revealed about pediatric atherogenesis, and a potential clinical role for ultrasound in pediatric risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Testing for endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Determinants of arterial nitrate-mediated dilatation in children: role of oxidized low-density lipoprotein, endothelial function, and carotid intima-media thickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Insulin resistant young subjects at risk of accelerated atherosclerosis exhibit a marked reduction in peripheral endothelial function early in life but not differences in intima-media thickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Effect of short-term weight loss on the metabolic syndrome and conduit vascular endothelial function in overweight adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Inflammation, insulin, and endothelial function in overweight children and adolescents: the role of exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Passive Smoking and Impaired Endothelium-Dependent Arterial Dilatation in Healthy Young Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Vascular endothelial and smooth muscle function relates to body mass index and glucose in obese and nonobese children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Improvement of early vascular changes and cardiovascular risk factors in obese children after a six-month exercise program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Oxidative stress is associated with arterial dysfunction and enhanced intima-media thickness in children with hypercholesterolemia: the potential role of nicotinamide-adenine dinucleotide phosphate oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Arterial function in youth: window into cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Early statin therapy restores endothelial function in children with familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Endothelial dysfunction occurs in children with two genetic hyperlipidemias: improvement with antioxidant vitamin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Biological correlates of day-to-day variation in flow-mediated dilation in individuals with Type 2 diabetes: a study of test-retest reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Within-subject variability of flow-mediated vasodilation of the brachial artery in healthy men and women: implications for experimental studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

34th Bethesda Conference: Task force #3--What is the spectrum of current and emerging techniques for the noninvasive measurement of atherosclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

34th Bethesda Conference: Task force #2--What is the pathologic basis for new atherosclerosis imaging techniques?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Noninvasive tests of vascular function and structure: why and how to perform them

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Carotid intima-media thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Improved common carotid elasticity and intima-media thickness measurements from computer analysis of sequential ultrasound frames.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Intima-media thickness and diameter of carotid and femoral arteries in children, adolescents and adults from the Stanislas cohort: effect of age, sex, anthropometry and blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: The Muscatine Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Carotid atherosclerosis in adolescents and young adults with IDDM. Relation to urinary endothelin, albumin, free cortisol, and other factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Measurement of arterial wall thickness as a surrogate marker for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Statin treatment in children with familial hypercholesterolemia: the younger, the better

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Stiffness of the aortic wall in hypercholesterolemic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Age-associated changes in arterial elastic properties in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Childhood blood pressure as a predictor of arterial stiffness in young adults: the bogalusa heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Effects of low and high doses of atorvastatin on arterial compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

C-reactive protein concentration and cardiovascular disease risk factors in children: findings from the National Health and Nutrition Examination Survey 1999-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Plasma C-reactive protein levels and their relationship to anthropometric and lipid characteristics among children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Adhesion molecules and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Soluble intercellular adhesion molecule-1 and interleukin-6 levels reflect endothelial dysfunction in patients with primary hypercholesterolaemia treated with atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Reduction in serum levels of adhesion molecules, interleukin-6 and C-reactive protein following short-term low-dose atorvastatin treatment in patients with non-familial hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

The metabolic basis of arginine nutrition and pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Endogenous nitric oxide synthesis inhibitor asymmetric dimethyl L-arginine accelerates endothelial cell senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Asymmetric dimethylarginine upregulates LOX-1 in activated macrophages: role in foam cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

ADMA and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Effects of atorvastatin on oxidized low-density lipoprotein, low-density lipoprotein subfraction distribution, and remnant lipoprotein in patients with mixed hyperlipoproteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

Pediatric issues and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.3.195

10.1515/JPEM.2009.22.3.195

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference